201. Inhibition of endogenous leptin protects mice from arterial and venous thrombosis
- Author
-
Katrin Schäfer, Stavros Konstantinides, David J. Loskutoff, Jaap G. Neels, and Claudia Dellas
- Subjects
Leptin ,medicine.medical_specialty ,Arterial Occlusive Diseases ,Receptors, Cell Surface ,Ferric Compounds ,Mice ,Chlorides ,Jugular vein ,Internal medicine ,medicine ,Animals ,Antibodies, Blocking ,Venous Thrombosis ,business.industry ,medicine.disease ,Thrombosis ,Pulmonary embolism ,Mice, Inbred C57BL ,Venous thrombosis ,Endocrinology ,medicine.anatomical_structure ,Circulatory system ,Receptors, Leptin ,Cardiology and Cardiovascular Medicine ,business ,Blood vessel ,Artery - Abstract
Objective— Human obesity is associated with an increased risk for arterial and venous thrombosis and with elevated levels of leptin in the blood. Leptin administration promotes arterial thrombosis in mice, and leptin-deficient ob/ob mice have an attenuated thrombotic response to injury. Thus, endogenous leptin may regulate arterial and venous thrombosis in vivo. Experiments were performed to test this hypothesis. Methods and Results— A leptin-neutralizing antibody was administered intravenously into wild-type mice 15 minutes before carotid artery injury with ferric chloride. The antibody-treated mice demonstrated prolonged times to thrombotic occlusion and formed unstable, embolizing thrombi. Thus, inhibiting leptin converted the thrombotic phenotype of wild-type mice into one that closely resembled that of ob/ob mice. The effect of leptin inhibition on venous thrombosis and pulmonary embolism was also investigated. Injection of a mixture of collagen and epinephrine into the jugular vein induced fatal pulmonary embolism in >90% of the control wild-type mice but in Conclusions— Inhibition of circulating leptin protects against arterial and venous thrombosis in mice and possibly in hyperleptinemic obese individuals.